National Medicare Claims (Medicare), Veterans Health Administration (VHA), ≥65 years old
OW and OB
Colorectal cancer screening
There was increased CRC screening in overweight VHA care recipients OR 1.12 . There were no other significant associations between CRC screening and OB (VHA and Medicare) and OW Medicare beneficiaries.
OW and OBII were positively associated with sigmoidoscopy in last 5 years in men. OR 1.25 [1.05–1.51], 1.21 [1.03–1.75]. OBI and OBII were negatively associated with sigmoidoscopy in last 5 years in women. OR 0.86 [0.78–0.94], OR 0.88 [0.79–0.99].
Morbid obesity was negatively associated with endoscopy in women only. RD − 4.9 [−7.7 to −1.9]. There was no significant association between morbid obesity and endoscopy in men.
Morbid obesity in women only was negatively associated with FOBT. RD − 3.7 [−7.7 to −1.9]. There was no significant association between FOBT and morbid obesity in men.
Morbid obesity in women only was negatively associated with overall CRC screening. RD − 5.6 [−8.5 to −2.6]. There was no association between overall CRC screening and morbid obesity in men.
2 population-based case-control studies of colorectal cancer patients, interviewer-administered questionnaire
OW and OB
Sigmoidoscopy
OW and OB in women were positively associated with sigmoidoscopy (OR 1.8 and 2.3, resp., ). There was no significant association between sigmoidoscopy and OW or OB in men.
Cancer Prevention Study (CPS) II Nutrition Cohort 1997
OW and OB, collapsed OBI and II, morbid obesity ≥40
Endoscopy
OBI and OBII were negatively associated with endoscopy in men. OR 0.88 [.82–.94]. OBI and OBII were negatively associated with endoscopy in women. OR 0.8 [.81–.91]. Morbid obesity in women was negatively associated with endoscopy. OR 0.71 [0.59–0.85].
1Predictors: OW: Overweight, OB: Obese, OBI: Obese I, OBII: Obese II, OBIII: Obese III.